Hanly L, Rieder MJ, Huang SH, Vasylyeva TL, Shah RK, Regueira O, Koren G
This proactive approach safeguards valuable research materials and reinforces the credibility of scientific discovery
One-year intranasal application of growth hormone releasing peptide-2 improves body weight and hypoglycemia in a severely emaciated anorexia nervosa patient
View our Certificates of Analysis (COA) by clicking here Due to the specialised research nature of our products, we do not accept returns or exchanges once an order has been placed
When prescribed and monitored by a qualified healthcare provider, these medications can: Improve insulin sensitivity Reduce appetite and food cravings Support weight loss in certain patients However, outside of a controlled medical environmen t, these effects can become unpredictable and even dangerous